Intratumoral administration of F. nucleatum in BC has been confirmed to reduce the number of infiltrated CD4+ and CD8+ cells, which are typical immune related T cells, thereby allowing tumor cells to evade immune surveillance (7). The gene discussed is CD4; the disease is neoplasm.